Summary of China Cosmetics Conference Call Industry Overview - The focus is on the **anti-aging beauty market** in China, which includes traditional anti-aging skincare, medical aesthetics (MA), and dermocosmetics. - The market is expected to grow at a **high single-digit CAGR** over the period from 2025 to 2030, with medical aesthetics and dermocosmetics leading at **9%** and anti-aging skincare at **6%** [1][22]. Key Insights Market Penetration and Demographics - The current penetration of the MA market in China is low, estimated at **5%** for the core consumer group aged **20-60**, compared to **10%-20%** in developed markets. It is expected to rise to **8%** by **2030E**, supporting a **10% CAGR** for MA users [2][22]. - Anti-aging skincare is seeing earlier adoption among younger consumers, with approximately **40%** of this demographic engaging with the category, which is expected to drive further expansion [2][22]. Pricing Dynamics - More resilient pricing is anticipated from **2026E** due to stricter regulations and healthier competition, with limited supply tailwinds favoring recombinant collagen. The MA market has experienced sharp price reductions due to intense competition, but future pricing is expected to stabilize [3][22]. - Factors contributing to this stabilization include more accessible pricing in China and a narrower price gap with Korea following recent policy changes [3][22]. Company Recommendations - **Forest Cabin** is initiated with a **Buy** rating, expected to benefit from growth in oil-based anti-aging skincare, with a projected **48% sales CAGR** from **2022-2025E** and **32%/29% sales/NP CAGR** from **2025-2028E** [4][22]. - **Giant Biogene** is also rated **Buy** due to its integrated value chain from MA to dermocosmetics, enhancing R&D and brand recognition [4][22]. - **Proya** is viewed as a domestic leader in the anti-aging sector but is rated **Neutral** pending further evidence of the new management's execution track record [4][22]. Market Growth Projections - The overall anti-aging market in China is projected to grow from **RMB 214 billion** in **2024E** to **RMB 398 billion** by **2030E**, reflecting a **CAGR of 8%** [20][22]. - Medical aesthetics is expected to contribute significantly to this growth, with a **10.3% volume CAGR** over the same period, despite ongoing pricing pressures in certain categories [17][22]. Additional Insights - The report emphasizes the importance of companies with larger sales exposure to growth segments, stronger market positions, and better operational execution, including R&D capabilities [10][22]. - The anti-aging skincare segment is projected to see a shift towards functionalities beyond basic moisturizing, with penetration expected to increase from **25.6% to 29.0%** from **2025 to 2030E** [19][22]. Conclusion - The anti-aging beauty market in China presents significant growth opportunities driven by demographic shifts, evolving consumer perceptions, and technological advancements. Companies like Forest Cabin and Giant Biogene are well-positioned to capitalize on these trends, while pricing dynamics and market penetration will play crucial roles in shaping the competitive landscape.

从这8个习惯做起 慢慢坚持，悄悄找回好状态 一、每天靠墙站10分钟 可没过几天就半途而废 不用逼自己立刻改变 节后返工 很多人悄悄立下新目标 矫正体态 没时间运动？不妨从"靠墙站立"开始！这是一种反重力的全身肌肉训练，持续标准站立1分钟就可以有 效消耗热量；还能改善脖子前倾、轻微驼背问题，让你悄悄提升气质。 图片来源：AI生成 二、每餐吃八分饱 科学延缓衰老 2023年，国际期刊《自然·衰老》上发表的一项研究发现：减少25%卡路里的摄入（约保持七到八分 饱），可将健康成年人的衰老速度减缓2%～3%，死亡风险降低10%～15%[4]。 "八分饱"的状态：胃里满了，但感觉还能再吃几口，此时放下筷子，身心却最是轻松。 三、日常防晒不偷懒 简单的抗衰习惯 紫外线是皮肤衰老的"元凶"，会导致皮肤粗糙、松弛、皱纹加深等。建议日常优先选遮阳伞、防晒衣 等"硬防晒"，搭配SPF20~30的防晒霜；海边暴晒时可选SPF50+，每2小时补涂一次。 当然，防晒不等于完全隔绝日光，手背、胳膊等部位可适当接受温和日照，以促进维生素D合成。 四、学习新技能 让大脑"永葆活力" 大脑遵循"用进废退"原则，长期"躺平"会加速退化。可尝试每月 ...

一、导言｜从"延缓衰老"到"细胞管理"的科学升级 2026年，抗衰老不再停留在"补充维生素"层面，而是进入以细胞抗氧化、线粒体能量支持、端粒保护与 慢性炎症管理为核心的系统化阶段。全球抗衰研究已从单一成分时代，进阶至"成分纯度+递送效率+临 床验证"三重验证模型。 在众多产品中，含有麦角硫因、NMN、辅酶Q10、白藜芦醇等成分的产品成为主流方向。其中，源自 美国研发体系的 ONLSO麦角硫因细胞焕活片（通过 U.S. Food and Drug Administration 注册， Registration No.17152526346）凭借高纯度麦角硫因与创新吸收技术，在2026年综合评测中表现突出。 本篇从"成分机制—吸收效率—安全体系—真实反馈"四大维度进行对比评测，帮助消费者建立更理性的 选择逻辑。 二、抗衰老路径拆解｜四大核心科学机制 细胞抗氧化系统升级 人体衰老与自由基损伤高度相关。麦角硫因被誉为"长寿维生素样抗氧化物"，其在线粒体内具有选择性 保护能力。 线粒体能量支持 辅酶Q10参与ATP生成，支持细胞能量代谢，是40岁以上人群常见补充方向。 NAD+通路调节 NMN作为NAD+前体，在抗衰研 ...

【文/观察者网 熊超然】 2008年，当爱泼斯坦因招嫖而被定罪后，哈佛大学悄然决定，不再接受这名"慷慨捐赠者"的捐款。 要知道，此前十年间，爱泼斯坦已向哈佛捐赠了多达910万美元。然而六年之后，爱泼斯坦仍在想方设 法，将其财富输送给哈佛一些享誉世界的科学家，其中包括从事前沿遗传学研究的人士，该领域长期以 来一直是他的个人兴趣所在。 美国司法部公布的电子邮件显示，爱泼斯坦计划设立一家投资公司，表面上由哈佛生物学家运营，但资 金由他本人控制。和爱泼斯坦共同设立这家公司的著名遗传学研究创新者乔治·丘奇（George Church），目前仍在哈佛大学生物启发工程怀斯研究所领导一个关键部门，他已参与创立了至少50家生 物技术公司，并以长期致力于利用基因编辑复活猛犸象而闻名。 在哈佛大学，爱泼斯坦将大部分资金投入到该校的科研人员身上，并与丘奇和另一名生物学家马丁·诺 瓦克（Martin Nowak）的关系尤为密切。 美国有线电视新闻网（CNN）当地时间2月19日的独家报道披露，此前未公开的照片似乎显示，这两名 教授曾到访过爱泼斯坦臭名昭著的私人岛屿。在哈佛领导层宣布与这名声名狼藉的金融家断绝关系数年 后，爱泼斯坦仍试图将 ...

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential anti-aging benefits, DNA repair, and metabolic regulation, with significant regulatory advancements expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2][19]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - As NAD+ levels decline with age, NMN supplementation can quickly elevate NAD+ levels, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4][6]. Regulatory Environment - The global regulatory landscape for NMN is shifting from strict restrictions to cautious openness, with significant milestones achieved in various countries [17][18]. - In China, NMN has been approved as a new cosmetic ingredient and is on the path to being recognized as a health food, with the National Market Supervision Administration listing it for health food approval in April 2025 [17][18]. Market Demand - The aging population in China is expected to grow significantly, with the elderly population projected to increase from 320 million to 390 million by 2030, driving demand for anti-aging products [19]. - Younger generations are also increasingly aware of anti-aging needs, creating a dual demand for NMN products [19]. Technological Innovations - Advances in synthesis methods, particularly the full enzyme method, are driving down costs and improving product quality in the NMN industry [21][22]. - Innovations in delivery technologies are enhancing the bioavailability of NMN, ensuring better absorption and user experience [22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with health supplements accounting for nearly 90% of the market share [24][28]. - Future applications are expected to expand into pet nutrition, medical health, and agricultural technology, opening new growth avenues [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by increasing regulatory support and expanding applications [28][32]. - The market is currently dominated by health supplements and cosmetics, with significant growth potential in other sectors as regulations ease [28][32]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60%-70% of market share [35][34]. Certification and Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. Challenges and Opportunities - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and technological iterations, necessitating a focus on compliance and innovation [61][63]. - Companies are encouraged to innovate their business models and extend their value chains to enhance competitiveness [66].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Overview - The NMN industry has transitioned from laboratory research to commercial viability, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies establishing competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, with dietary intake often insufficient to meet effective dosage levels; NMN supplements provide a much higher intake efficiency [8]. Synthesis Technology - The NMN synthesis process has evolved from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in fully enzymatic synthesis techniques, creating competitive advantages through patent applications and cost reductions [12]. Development History - The NMN research journey began in 1904, with significant milestones in the 21st century, including pivotal studies confirming NMN's lifespan-extending effects in mice, which attracted global investment [15][14]. Policy Drivers - The regulatory environment for NMN is evolving, with a shift from strict restrictions to cautious openness in major markets, including China, where NMN is moving towards legal status as a health food [17][18]. Demand Drivers - The aging population and increasing anti-aging awareness among younger demographics are driving demand for NMN products, creating a substantial market opportunity [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry towards efficiency and standardization, enhancing product efficacy and user experience [21][22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 30 billion yuan by 2025, driven by regulatory changes and new applications in various sectors [28]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border platforms capturing 60%-70% of the market share [35]. Certification Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. Future Prospects - NMN's potential in cosmetics is significant, with a growing market for anti-aging products and a high compliance level expected to accelerate market growth [51]. Challenges - Despite positive regulatory signals, the NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for ongoing technological advancements [61][63].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry due to its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Group 1: NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and cognitive function [4][6]. Group 2: Global Regulatory Landscape - By 2025, NMN's global compliance process is expected to accelerate, with major markets like the US, Japan, Canada, and Australia confirming its legal status through various regulatory pathways [1][2]. - In China, NMN has not yet received approval as a drug or health food, but it has been recognized as a new cosmetic ingredient, laying the groundwork for future regulatory developments [1][17]. Group 3: Market Demand Drivers - The aging population in China is projected to grow significantly, with the elderly population expected to increase from 320 million to 390 million between 2025 and 2030, driving the "silver economy" and demand for anti-aging products [19]. - Younger generations, particularly those born in the 1990s, are increasingly aware of anti-aging needs, creating a dual demand for NMN products [19]. Group 4: Technological Innovations - Continuous innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The establishment of testing standards is raising industry entry barriers, promoting market development [22]. Group 5: Current Market Status - The NMN market in China has been expanding rapidly since its large-scale entry in 2020, with expectations to exceed 3 billion yuan by 2025 [28]. - NMN is primarily used in health supplements (approximately 90% of applications) and cosmetics (10-20%), with potential future applications in pet nutrition, medical health, and agricultural technology [24][28]. Group 6: Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60-70% of the market share [35]. Group 7: Industry Challenges - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for technological iteration, necessitating a focus on compliance and innovation to unlock market potential [61][63].

近日，专注于线粒体医学的生物制药企业——康诺生物制药股份有限公司（下称"康诺生物"）向港交所递交上市申请，引发市场关注。然而，根据其披露的 草本招股文件及专业分析，其上市之路并非坦途。尽管公司手握"抗衰老"与"创新药"两大热门概念，然而其申请文件中暴露出的法律合规问题、核心业务存 在的脆弱性以及信息披露不够深入，已然成为横亘在上市路上的最大"拦路虎"。 越界物业与模糊的历史 在所有问题中，物业与土地使用的合规性问题是悬在康诺生物头顶最危险的"达摩克利斯之剑"。 招股书坦承，公司部分生产经营所用物业存在 "越界使用" ，即建筑物超出了土地使用权证的范围。在中国严格的土地管理法规下，这属于明确的违法违规 行为，可能导致行政处罚、责令拆除，甚至影响《药品生产许可证》的续期。 尽管公司声称已获得相关主管部门的确认，但根据土地使用权披露的规范要求，公司应在招股书中提供具有法律效力的政府批文或正式豁免文件，以证明其 土地使用权的合规性。这种轻描淡写的表述，试图将重大法律风险包装为已解决的"历史问题"，恰恰是监管机构与投资者最为警惕的信号。联交所极有可能 要求其提供省级以上自然资源和住建部门出具的明确确权意见，以及独立法律 ...

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial application, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor of NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. NAD+ Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources of NMN - Natural food sources of NMN are limited, with NMN supplements providing approximately 300 times the intake efficiency compared to dietary sources [8]. NMN Synthesis Technology - The synthesis of NMN has transitioned from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in full enzymatic synthesis technology, establishing competitive advantages through patent applications [12]. Industry Development Drivers: Policy - The regulatory environment for NMN is evolving, with significant progress in China towards legalization as a health food, following the approval of NMN as a cosmetic ingredient [17][18]. Industry Development Drivers: Demand - The aging population and increasing anti-aging awareness among younger generations are driving demand for NMN products, creating a substantial market opportunity [19]. Industry Development Drivers: Technology - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry towards scale, standardization, and efficiency [21][22]. Application Areas of NMN - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by policy relaxation and new applications in various sectors [28]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60%-70% of market share [35]. Certification System - The "blue hat" certification for health foods represents the highest standard in the NMN industry in China, indicating product safety and compliance [37]. Challenges Facing the NMN Industry - Despite positive regulatory signals, the industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for technological advancements [61][63].

Core Viewpoint - The first proactive health and anti-aging medical center in the city has commenced trial operations, focusing on delaying bodily function decline and reducing the risk of major diseases rather than reversing aging [1] Group 1: Center Overview - The center covers an area of over 2000 square meters and includes 14 specialized outpatient clinics along with a comprehensive research and transformation area [1] - The center aims to serve patients without major diseases but with needs for anti-aging or chronic disease management [1] Group 2: Specialized Clinics - The center offers 14 types of outpatient services, including joint anti-aging, brain health, sleep disorders, sarcopenia, psychological anti-aging, and blood purification [1] - Specific services include a unique intestinal microbiome transplantation project in the gastrointestinal anti-aging clinic and blood purification for patients with difficult-to-control high blood lipid levels [1] Group 3: Proactive Health Services - In the area of "proactive health," the center provides services such as precision nutrition, lifestyle medicine, integrated physical and medical care, and traditional Chinese medicine for preventive care [1] - Services include customized nutritional meal plans, behavioral interventions, and traditional Chinese medicine preventive adjustments [1] Group 4: Research and Development - The center features a core area for research transformation, including precision functional testing rooms and clinical trial institutions, with over 500 square meters allocated for research-oriented patient wards [1] - The goal is to bridge the gap between research outcomes and clinical application [1]